# Discriminator report

## Scenario echo
Human pancreas, all cell types in the tissue, with age, sex, and condition unspecified/null; condition therefore means healthy/baseline, and there are no notes requesting a special developmental, disease, pathway, or subtype emphasis.

## Rating: minor
The blueprint is broadly biologically plausible and covers the major human pancreas compartments: acinar, ductal/centroacinar, endocrine islet subtypes, stellate/fibroblast, vascular and lymphatic endothelium, mural cells, immune subsets, mast cells, and Schwann/neural cells. It needs targeted refinement for a missing generic cell-cycle state, cleaner quiescent stellate coverage, and a few marker/axis specificity issues, but the overall structure is not broken.

## Findings

### Minor issues
- **general coverage: cycling/proliferative state** — Healthy human pancreas atlases can still contain small cycling populations, especially immune, stromal, ductal, or dissociation-associated proliferative cells. The current blueprint has no axis for a generic cell-cycle/proliferation state, so cycling cells may be forced into lineage axes only.
  *Fix:* Add a broadly applicable proliferation module and plain or state-scoped axis using canonical markers such as `MKI67`, `TOP2A`, `PCNA`, `PCLAF`, `STMN1`, `HMGB2`, `CENPF`, `UBE2C`, `MCM5`, and `TYMS`.

- **fibroblast_stellate / stellate_activation_state** — The blueprint includes a fibroblast/stellate identity and an activated myofibroblast state, but quiescent pancreatic stellate cells are not cleanly represented. The current `fibroblast_stellate` module is mostly ECM fibroblast markers, while the activation module overlaps strongly with smooth-muscle/contractile genes (`ACTA2`, `TAGLN`, `MYL9`, `TPM2`) and collagen genes.
  *Fix:* Add or retune a quiescent stellate module/axis with markers such as `RGS5`, `PDGFRB`, `DES`, `GFAP`, `LRAT`, `RBP1`, `COL6A1`, `COL6A2`, and `APOD`, and keep the activated axis as a state within stromal/stellate cells with less dependence on genes shared by vascular smooth muscle.

- **beta_maturity_within_islets** — The beta maturity axis is gated by `beta_cell` but subtracts alpha and delta modules. That makes the axis partly a beta-vs-other-endocrine contrast rather than a true mature-vs-immature/stressed beta state.
  *Fix:* Either remove the alpha/delta negatives from this gated state axis, or define a biologically meaningful immature/stressed beta-cell negative module and contrast against that within the beta gate.

- **gamma_pp_cell and epsilon_ghrelin_cell marker specificity** — The rare endocrine subtype modules are directionally plausible, but some markers are weakly specific. `gamma_pp_cell` is very short and includes `TM4SF4`, which is more epithelial/ductal-associated than PP-cell defining. `epsilon_ghrelin_cell` includes `RFX6`, a broader endocrine/progenitor transcription factor, and `GHSR`, which also appears in delta-cell biology.
  *Fix:* Strengthen rare endocrine modules around the hormone genes and endocrine secretory context. For PP/gamma cells, keep `PPY`/`PYY` and add more endocrine-compatible markers where possible; for epsilon cells, keep `GHRL`/`MBOAT4`/`SLC18A2` and avoid using broad progenitor or overlapping delta markers as primary discriminators unless needed.

- **immune_t_nk_bias / immune_b_plasma_bias and sibling axes** — The immune branch is biologically plausible but somewhat overcomplete: broad `t_nk_lymphoid` and `b_plasma_cell` axes are followed immediately by separate T, NK, B, and plasma axes using many of the same genes. This is not biologically wrong, but it adds redundant dimensions.
  *Fix:* Tighten the immune branch by making the broad lymphoid/B-lineage modules serve as gates or coarse context only, and ensure the final T, NK, B, and plasma axes carry the main subtype discrimination. No deletion is required if the redundancy is useful for coarse-to-fine geometry.

## Out of scope (FYI, not actionable for the Generator)
- The blueprint does not need a developmental gating tree because the scenario notes are null.
- Rare ductal ionocyte/tuft-like populations and detailed arterial/venous/capillary endothelial zonation would be reasonable optional refinements, but they are not required for this broad healthy pancreas scenario.

## Summary for the next round
Focus on adding a generic cycling/proliferation state, clarifying quiescent versus activated stellate biology, and tightening the beta maturity and rare endocrine subtype marker logic. The current compartment structure is sound, so this should be a targeted refinement rather than a rebuild.
